India to launch its first homegrown bird flu vaccine on November 20
text_fieldsIndia will launch its first homegrown bird flu vaccine on November 20, marking a major step towards protecting the country's poultry sector from avian influenza outbreaks.
The vaccine has been developed specifically against the H5N1 Clade 2.3.2.1a strain.
Union Agriculture Minister Shivraj Singh Chouhan will formally launch it in Bhopal, the government has announced.
India has reported more than 500 avian influenza outbreaks since the first case was detected in 2006. Both H5N1 and H5N8 strains have caused outbreaks, resulting in mass culling and financial losses for poultry farmers.
Recent outbreaks have highlighted the scale of the problem. Tamil Nadu culled 40,000 chickens in November, while 26,000 birds were culled in Alappuzha, Kerala, following an outbreak.
Avian influenza can cause mortality rates approaching 100% among infected birds. Outbreaks also disrupt poultry supplies and cause substantial economic losses. Countries such as China, Egypt, and Vietnam have used bird flu vaccines for years.
The threat is not limited to poultry. H5N1 can also infect humans. According to the World Health Organization, there have been 1,003 human infections and 479 deaths globally since 2003.
The new vaccine could help reduce losses among poultry farmers and strengthen food security. An uncontrolled outbreak has been estimated to put more than 20% of India's poultry population at risk and reduce the country's GDP growth by up to 1.5%.
However, vaccination alone cannot guarantee protection against outbreaks or prevent the virus from spreading. Surveillance, testing, farm hygiene and biosecurity will remain essential.
The government has not yet announced when the vaccine will reach poultry farms or disclosed its price and vaccination schedule.













